Top 10 botanical ingredients in 2010 anti-aging creams

Journal of Cosmetic Dermatology

Volumn 9, Issue 3, 2010, Pages 218-225

  Cronin, Hyland ^a   Draelos, Zoe Diana ^b  

^a GEISINGER HEALTH SYSTEM   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti aging; Antioxidant; Botanical; Cosmeceutical; Cosmetic dermatology; Topical anti aging

Indexed keywords

AFRAMOMUM ANGUSTIFOLIUM EXTRACT; ANTIOXIDANT; CITRONELLOL; DIOSGENIN; GLYCYRRHIZA GLABRA EXTRACT; KINETIN; LIMONENE; PRIMROSE OIL; ROSMARINUS OFFICINALIS EXTRACT; THIONEINE; UNCLASSIFIED DRUG; VITIS VINIFERA EXTRACT;

ANTIOXIDANT ACTIVITY; ARTICLE; CREAM; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; PHYTOTHERAPY; PRIORITY JOURNAL;

ANTIOXIDANTS; CYCLOHEXENES; DIOSGENIN; ERGOTHIONEINE; GRAPE SEED EXTRACT; HUMANS; KINETIN; MONOTERPENES; OENOTHERA; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; ROSA; SKIN AGING; TERPENES; ZINGIBERACEAE;

EID: 77956255069     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2010.00516.x     Document Type: Article

References (103)

1. Al-Sereiti MR. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 1999, 37:124-30.
2. Fu Y. Investigation of antibacterial activity of rosemary essential oil against propionibacterium acnes with atomic force microscopy. Planta Med 2007, 73:1275-80.
3. Weckesser S. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine 2007, 14:508-16.
4. Mangena T, Muyima N. Comparative evaluation of the antimicrobial activities of essential oils of Artemisia afra, Pteronia incana and Rosmarinus officinalis on selected bacteria and yeast strains. Lett Appl Microbiol 1999, 28:291-6.
5. Oluwatuyi M. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 2004, 65:3249-54.
6. Bozin B. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 2007, 55:7879-85.
7. Moreno S. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res 2006, 40(2):223-31.
8. Nolkemper S. Antiviral effect of aqueous extracts from species of the Lamiaceae family against herpes simplex virus type 1 and type 2 in vitro. Planta Med 2006, 72:1378-82.
9. Angioni A. Chemical composition, plant genetic differences, antimicrobial and antifungal activity investigation of the essential oil of Rosmarinus officinalis L. J Agric Food Chem 2004, 52:3530-5.
10. Ozcan M. Chemical composition and antifungal activity of rosemary (Rosmarinus officinalis L.) oil from Turkey. Int J Food Sci Nutr 2008, 59(7-8):691-8.
11. Altinier G. Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem 2007, 55:1718-23.
12. Cheung S, Tai J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 2007, 17:1525-31.
13. Scheckel K. Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines. J Nutr 2008, 138:2098-105.
14. Sancheti G, Goyal PK. Effect of Rosmarinus officinalis in modulating 7,12-dimethylben(a)anthracene induced skin tumorigenesis in mice. Phytother Res 2006, 20:981-6.
15. Huang MT. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994, 54:701-8.
16. Minnunni M. Natural antioxidants as inhibitors of oxygen species induced mutagenicity. Mutat Res 1992, 269:193-200.
17. Offord EA. Rosemary components inhibit benzo(a)pyrene induced genotoxicity in human bronchial cells. Carcinogenesis 1995, 16:2057-62.
18. Singletary K. Inhibition by rosemary and carnosol of 7,12-dimethylben(a)anthracene (DMBA)-induced rat mammary tumorigenesis in vivo DMBA-DNA adduct formation. Cancer Lett 1996, 104:43-8.
19. Moran AE. Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min?+(Min/+) mouse. Cancer Res 2005, 65:1097-2104.
20. Huang SC. Carnosol inhibited the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappaB and c-jun. Biochem Pharmacol 2005, 69:221-32.
21. Chan MM. Effects of three dietary phytochemicals from tea, rosemary, and rumeric on inflammation-induced nitrite production. Cancer Lett 1995, 96:23-9.
22. Rababah TM. Total phenolics and antioxidant activities of fenugreek, green tea, black tea, grape seed, rosemary, guto kola, and ginkgo extracts, vitamin E and tert-butylhydroquinone. J Agric Food Chem 2004, 52:5183-6.
23. Yesil-Celiktas O. Determination of phenolic content and antioxidant activity of extracts obtained from Rosmarinus officinalis' calli. J Plant Physiol 2007, 164:1536-42.
24. Lamaison JL. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Pharm Acta Helv 1991, 66:185-8.
25. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Foods, Drugs, and Cosmetics 1996, 2nd edn, John Wiley & Sons, New York
26. Kim H, Kim K. Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro. J Agric Food Chem 2003, 51:1586-91.
27. Topal U. Chemical compositions and antioxidant properties of essential oils from nine species of Turkish plants obtained from supercritical carbon dioxide extraction and steam distillation. Int J Food Sci Nutr 2008, 59(7-8):619-34.
28. Calabrese V. Biochemical studies of a natural antioxidant isolated from rosemary and its application in cosmetic dermatology. Int J Tissue React 2000, 22(1):5-13.
29. Papageorgiou V. Variation of the chemical profile and antioxidant behavior of Rosmarinus officinalis L. and salvia fruticosa miller grown in Greece. J Agric Food Chem 2008, 56:7254-64.
30. Del Bano MJ. Phenolic diterpenes, flavones and rosmarinic acid distribution during the development of leaves, flowers, stems and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem 2003, 51:4247-53.
31. Perez-Fons L. Rosemary (Rosmarinus officinalis) diterpenes affect lipid polymorphism and fluidity in phospholipid membranes. Arch Biochem Biophys 2006, 453:224-36.
32. Martin R. Photoprotective effect of a water-soluble extract of Rosmarinus officinalis L. against UV-induced matrix metalloproteinase-1 in human dermal fibroblasts and reconstructed skin. Eur J Dermatol 2008, 18(2):128-35.
33. Inui S, Katayama I. Allergic contact dermatitis induced by rosemary leaf extract in a cleansing gel. J Dermatol 2005, 32:667-9.
34. Martinez-Gonzalez M. Concomitant allergic contact dermatitis due to Rosmarinus officinalis (rosemary) and Thymus vulgaris (thyme). Contact Dermatitis 2007, 56:49-50.
35. Fernandez L. Allergic contact dermatitis from rosemary (Rosmarinus officinalis L.). Contact Dermatitis 1997, 37:248-9.
36. Hjorther AB. Occupational allergic contact dermatitis from carnosol, a naturally-occurring compound present in rosemary. Contact Dermatitis 1997, 37:99-100.
37. Klarman EG. Perfume dermatitis. Ann Allergy 1958, 16:425-34.
38. Guin JD. Rosemary cheilitis: one to remember. Contact Dermatitis 2001, 45:63.
39. Armisen M. Photoaggravated allergic contact dermatitis due to Rosmarinus officinalis cross-reactive with Thymus vulgaris. Contact Dermatitis 2003, 48:52-3.
40. Katiyar S. Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system. Mol Nutr Food Res 2008, 52(Suppl 1):S71-6.
41. Wright T. Chemoprevention of nonmelanoma skin cancer. JAAD 2006, 54(6):933-50.
42. Orallo F. Trans-resveratrol: a magical elixir of eternal youth? Curr Med Chem 2008, 15:1887-98.
43. Orallo F. Comparative studies of the antioxidant effects of Cis- and Trans-resveratrol. Curr Med Chem 2006, 13:87-98.
44. Cornacchione S. In vivo skin antioxidant effect of a new combination based on a specific Vitis vinifera shoot extract and a biotechnological extract. J Drugs Dermatol 2007, 6(6):S8-13.
45. Sharma S. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-KB signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther 2007, 6(3):995-1005.
46. Amer M, Maged M. Cosmeceuticals versus pharmaceuticals. Clin Dermatol 2009, 27:428-30.
47. Monagas M. Commercial dietary ingredients from Vitis vinifera L. leaves and grape skins: antioxidant and chemical characterization. J Agric Food Chem 2006, 54:319-27.
48. Alam A. Chemopreventative effect of Vitis vinifera extract on 12-O-tetradecanoyl-13-phorbol acetate-induced cutaneous oxidative stress and tumor promotion in murine skin. Pharmacol Res 2002, 46(6):557-64.
49. Meeran S. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate caused skin tumor promotion in 7,12-dimethylben(a)anhtracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 2009, 30(3):520-8.
50. Kowalczyk M. Differential effects of several phytochemicals and their derivatives on murine keratinocytes in vitro and in vivo: implications for skin cancer prevention. Carcinogenesis 2009, 30(6):1008-15.
51. Gilpin S. In vitro human skin penetration of geraniol and citronellol. Dermatitis 2010, 21(1):41-8.
52. Taylor WG, Schreck CE. Chiral-phase capillary gas chromatography and mosquito repellent activity of some oxazolidine derivatives of (+)- and (-)-citronellol. J Pharm Sci 1985, 74:534-9.
53. http://www.epa.gov/pesticides/biopesticides/ingredients/factsheets/factsheet_167004.htm, US EPA Citronellol Fact Sheet,
54. Buckley DA. Fragrance ingredient labeling in products on sale in the U.K. Br J Dermatol 2007, 157:295-300.
55. Larsen WG. Fragrance contact dermatitis: a worldwide multicenter investigation (Part II). Contact Dermatitis 2001, 44:344-6.
56. Frosch PJ. Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis 2002, 47:78-85.
57. Keil H. Contact dermatitis due to oil of citronellol. J Invest Dermatol 1947, 8:327.
58. Storrs F. Fragrance. Contact allergen of the year. Dermatitis 2007, 18(1):3-7.
59. Frosch PJ. Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products. Contact Dermatitis 2005, 52:216-25.
60. Heydorn S. Fragrance allergy in patients with hand eczema - a clinical study. Contact Dermatitis 2003, 48:317-23.
61. Vuilleumier C. Multi-dimensional visualization of physical and perceptual data leading to a creative approach in fragrance development. Perfumer & Flavorist 2008, 33:54-61.
62. Matura M. Oxidized citrus oil (R-limonene): a frequent skin sensitizer in Europe. JAAD 2002, 47(5):709-14.
63. Christensson J. Air oxidation increases skin irritation from fragrance terpenes. Contact Dermatitis 2009, 60:32-40.
64. Shafer L, Kragballe K. Supplementation with evening primrose oil in atopic dermatitis: effect on fatty acids in neutrophils and epidermis. Lipids 1991, 26:557-60.
65. Morse PF. Meta-analysis of placebo controlled studies of the efficacy of Epogram in the treatment of atopic eczema relationship between plasma fatty acid changes and clinical response. Br J Dermatol 1989, 121:75-90.
66. Yates J. Do nonmedicated topicals relieve childhood eczema? J Fam Pract 2009, 58(5):280-1.
67. Yoon S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol Appl Skin Physiol 2002, 15:20-5.
68. Whitaker DK. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results. Dermatology 1996, 193:115-20.
69. Granlund H. Treatment of childhood eczema. Paediatr Drugs 2002, 4(11):729-35.
70. Cho H-S. Anti-wrinkling effects of the mixture of vitamin C, vitamin E, pycnogenol and evening primrose oil, and molecular mechanisms on hairless mouse skin caused by chronic ultraviolet B irradiation. Photodermatol Photoimmunol Photomed 2007, 23:155-62.
71. Gaby A. Natural remedies for scleroderma. Altern Med Rev 2006, 11(3):188-95.
72. Zaugg J. Quantitative analysis of anti-inflammatory and radical scavenging triterpenoid esters in evening primrose seeds. J Agric Food Chem 2006, 54:6623-8.
73. Morris G. Modulation of the cell kinetics of pig skin by the topical application of evening primrose oil of Lioxasol. Cell Prolif 1997, 30:311-23.
74. Gehring W. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Arzneimittelforschung 1999, 49(II):635-42.
75. Ramesh G, Das UN. Effect of evening primrose and fish oils on two stage skin carcinogenesis. Prostaglandins Leukot Essent Fatty Acids 1998, 59(3):155-61.
76. Draelos Z. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther 2007, 20:308-13.
77. Halder RM, Richard GM. Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 2004, 9(6):1-3.
78. Yokota T. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998, 11:355-61.
79. Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc 2008, 13:20-4.
80. Saeed M. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 2003, 14:153-7.
81. Bonnet-Duquennoy M. Transcriptional effect of an Aframomum angustifolium seed extract on human cutaneous cells using low-density DNA chips. J Cosmet Dermatol 2007, 6:128-34.
82. Talbourder S. Modulation of gene expression as a new skin anti-aging strategy. J Drugs Dermatol 2007, 6(6):s25-33.
83. Tada Y. Novel effects of diosgenin on skin aging. Steroids 2009, 74:504-11.
84. Hooker E. Final report of the amended safety assessment of Dioscorea villosa (wild yam) root extract. Int J Toxicol 2004, 23(S2):49-54.
85. Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 1994, 20:665-72.
86. Sharma SP. Plant growth hormone kinetin slows down ageing, prolongs the life span and slows down development of the fruitfly Zapronius paravittiger. Biochem Biophys Res Commun 1995, 216:1067-71.
87. Sharma SP. Increased longevity of kinetin-fed Zapronius is accompanied by their reduced fecundity and enhanced catalase activity. Biochem Mol Biol Int 1997, 41:869-75.
88. Chiu P. The clinical anti-aging effects of topical kinetin and niacinamide in asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol 2007, 6:243-9.
89. Olsen A. N6-furfuryladenine, kinetin, protects against fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 1999, 265:499-502.
90. Verbeke P. Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun 2000, 276:1265-70.
91. Barciszewski J. Furfural, a precursor of the cytokinin hormone kinetin and base propenals are formed by hydroxyl radical damage of DNA. Biochem Biophys Res Commun 1997, 238:317-9.
92. Barciszewski J. A mechanism for the in vivo formation of N6-furfuryladenine, kinetin, as a secondary oxidative damage product of DNA. FEBS Lett 1997, 414:457-60.
93. Kimura T, Doi K. Depigmentation and rejuvenation effects of kinetin on the aged skin of hairless descendants of Mexican hairless dogs. Rejuvenation Res 2004, 7(1):32-9.
94. McCullough JL, Weinstein GW. Clinical study to assess the safety and efficacy of topical kinetin 0.10% (Kinerase®) for photodamaged skin. J Cosmet Dermatol 2002, 15:29-32.
95. Vicanova J. Epidermal and dermal characteristics in skin equivalent after systemic and topical application of skin care ingredients. Ann N Y Acad Sci 2006, 1067:337-42.
96. Tournas JA. Ubiquinone, idebenone, and kinetin provide ineffective photoprotection to skin when compared to a topical antioxidant combinations of vitamins C and E with ferulic acid. J Invest Dermatol 2006, 126:1185-7.
97. Wu JJ. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 2007, 32:693-5.
98. Dong KK. A comparison of the relative antioxidant potency of L-ergothioneine and idebenone. J Cosmet Dermatol 2007, 6:183-8.
99. Obayashi K. L-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF-α and MMP-1 expression in UV-irradiated human dermal fibroblasts. J Cosmet Sci 2005, 56:17-27.
100. Smiles K. A hydroquinone formulation with increased stability and decreased potential for irritation. J Cosmet Dermatol 2007, 6:83-8.
101. Markova N. Skin cells and tissue are capable of using L-ergothioneine as an integral component of their antioxidant defense system. Free Radic Biol Med 2009, 46:1168-76.
102. He OC. The use of ozone as an oxidizing agent to evaluate antioxidant activities of natural substrates. Skin Pharmacol Physiol 2004, 17:183-9.
103. Decome L. Evaluation of photolyase (Photosome) repair activity in human keratinocytes after a single dose of ultraviolet B irradiation using the comet assay. J Photochem Photobiol B 2005, 79:101-8.